The market has been down on Zogenix, Inc. (ZGNX) stock recently. ZGNX gets a Bearish score from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends.
Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish.
InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion.
For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.
What's Happening With ZGNX Stock Today?
Zogenix, Inc. (ZGNX) stock is trading at $20.32 as of 10:54 AM on Thursday, Dec 17, a rise of $0.32, or 1.6% from the previous closing price of $20.00. The stock has traded between $19.71 and $20.53 so far today. Volume today is light. So far 478,458 shares have traded compared to average volume of 836,243 shares.
To see InvestorsObserver's Sentiment Score for Zogenix, Inc. click here.
More About Zogenix, Inc.
Zogenix Inc is engaged in developing and commercializing therapeutic solutions for people living with serious and life-threatening rare CNS disorders and medical conditions. Its product candidate includes ZX008, low-dose fenfluramine for the treatment of Dravet syndrome, LGS, and potentially other rare and catastrophic epilepsy disorders.
Click Here to get the full Stock Score Report on Zogenix, Inc. (ZGNX) Stock.
